ctrl K

Watchlist Price Alert

NeuroSense Therapeutics L... (NRSN)

NASDAQ: NRSN · Real-Time Price · USD

2.42

-0.03 (-1.22%)

At close: Jun 17, 2025, 2:03 PM

NeuroSense Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3.38M	2.64M	3.54M	11.06M	699K	895K
Short-Term Investments	n/a	n/a	3.55M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	23K	n/a	37K	35K
Other Long-Term Assets	23K	31K	n/a	n/a	n/a	n/a
Receivables	164K	166K	131K	178K	30K	18K
Inventory	n/a	n/a	-3.68M	-178K	-67	-18
Other Current Assets	35K	40K	36K	39K	n/a	n/a
Total Current Assets	4.4M	2.92M	7.38M	11.41M	729K	913K
Property-Plant & Equipment	150K	238K	306K	19K	13K	7K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	173K	269K	329K	19K	50K	42K
Total Assets	4.58M	3.18M	7.71M	11.43M	779K	955K
Account Payables	1.16M	1.46M	498K	39K	55K	23K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	261K	614K	413K	443K	29K	5K
Total Current Liabilities	1.99M	3.46M	1.73M	597K	120K	37K
Long-Term Debt	n/a	n/a	147K	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	1.52M	71K	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	1.59M	365K	1.83M	n/a	n/a
Total Liabilities	1.99M	4.94M	2.09M	2.42M	120K	37K
Total Debt	73K	142K	211K	1.83M	n/a	n/a
Common Stock	n/a	n/a	n/a	n/a	1K	1K
Retained Earnings	-36.66M	-26.12M	-20.79M	-8.45M	-4.41M	-1.58M
Comprehensive Income	n/a	n/a	26.41M	17.45M	5.06M	2.49M
Shareholders Equity	2.58M	-1.87M	5.62M	9.01M	659K	918K
Total Investments	n/a	22K	3.55M	n/a	37K	35K